Deal Announcements

Cebix Clears Venture Capital Debt Financing

Monday, March 12, 2012 5:55:00 AM PDT | VentureDeal Staff

   La Jolla, California  --  Biotechnology company Cebix has received $8.8 million in venture capital debt, according to an SEC regulatory filing.

Cebix is developing treatments for type I diabetic neuropathy.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds

Cebix is still seeking approximately $200,000 in additional financing according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1